'Air Xen' technique offers alternative way to implant gel stent

Pre-dissection to the superior conjunctival tissue aids in proper device insertion into the subconjunctival space and away from Tenon's tissue. Since the Xen gel stent was FDA approved in 2016, this less invasive glaucoma surgical device has been widely used to treat refractory glaucoma, decrea...

Full description

Saved in:
Bibliographic Details
Published inOcular Surgery News Vol. 39; no. 19; p. 26
Main Author Okeke, Constance O
Format Trade Publication Article
LanguageEnglish
Published Thorofare SLACK INCORPORATED 10.10.2021
Subjects
Cornea
Dissection
Glaucoma
Viscoelasticity
Online AccessGet full text

Cover

More Information
Summary:Pre-dissection to the superior conjunctival tissue aids in proper device insertion into the subconjunctival space and away from Tenon's tissue. Since the Xen gel stent was FDA approved in 2016, this less invasive glaucoma surgical device has been widely used to treat refractory glaucoma, decreasing IOP by shunting aqueous to the subconjunctival space. The device is a 6-mm long stent made of collagenderived noninflammatory gelatin material, preloaded in a disposable injector. Remove the viscoelastic from the anterior chamber with balanced salt solution and hydrate the corneal wounds.
ISSN:8750-3085